Aurobindo Pharma shares gain on U.S. FDA’s VAI classification of oral solid dosage unit
Aurobindo Pharma shares rise over 3% to a 52-week high after U.S. FDA classifies its manufacturing unit as VAI.
6 May 08:59 · The Hindu
last updated on 6 May 11:06